Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient Advisory Board for Chronic Rhinosinusitis – A EUFOREA initiative
Benoı̂t Pugin, Lauren Deneyer, Claus Bachert, et al.
Rhinology Journal (2019)
Open Access | Times Cited: 22

Showing 22 citing articles:

EPOS2020: A Major Step Forward
Wytske J. Fokkens
Rhinology Journal (2020) Vol. 58, Iss. 1, pp. 1-1
Open Access | Times Cited: 915
Executive Summary of EPOS 2020 Including Integrated Care Pathways
Wytske J. Fokkens, V J Lund, C. Hopkins, et al.
Rhinology Journal (2020) Vol. 58, Iss. 2, pp. 82-111
Open Access | Times Cited: 364
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 157
Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Federico Sireci, Giovanna Stilo, et al.
American Journal of Otolaryngology (2025) Vol. 46, Iss. 1, pp. 104597-104597
Open Access | Times Cited: 2
State-of-the-art overview on biological treatment for CRSwNP
Peter W. Hellings, E.W.M. Verhoeven, Wytske J. Fokkens
Rhinology Journal (2021)
Open Access | Times Cited: 61
White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA
Louise De Prins, Ulrike Raap, Tara Mueller, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 28
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care
Cosimo Galletti, Francesco Ciodaro, María Antonietta Barbieri, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104329-104329
Closed Access | Times Cited: 6
Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA
N. Claeys, Mary Teeling, Philippe Legrand, et al.
Frontiers in Allergy (2021) Vol. 2
Open Access | Times Cited: 35
EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR
G. K. Scadding, Diego M. Conti, Sophie Scheire, et al.
Frontiers in Allergy (2025) Vol. 5
Open Access
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024
Peter W. Hellings, Diego M. Conti, Xander Bertels, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA
T. Teeling, C. Djouder, Henry Laurens, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 3
EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care
Peter W. Hellings, Susanne Lau, Glenis Scadding, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 9
EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus
Diego M. Conti, Vibeke Backer, Beyer Kirsten, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 7
Open Access | Times Cited: 2
Rhinology Future Debates 2018, a EUFOREA Report
Emmanuel P. Prokopakis, Alexios Vardouniotis, Claus Bachert, et al.
Rhinology Journal (2020)
Open Access | Times Cited: 12
Rhinology in review: from COVID-19 to biologicals
Wytske J. Fokkens, Basile N. Landis, Claire Hopkins, et al.
Rhinology Journal (2021)
Closed Access | Times Cited: 9
Qualität in der Allergologie
Martin Wagenmann, Igor Stenin, Kathrin Scheckenbach
Laryngo-Rhino-Otologie (2020) Vol. 99, Iss. S 01, pp. S272-S300
Open Access | Times Cited: 7
Editorial: 2022 in review: rhinology
Diego M. Conti, Glenis Scadding
Frontiers in Allergy (2024) Vol. 5
Open Access
Patient perspectives on international multidisciplinary consensus criteria for chronic rhinosinusitis disease control
Ryan A. Cotter, Firas A. Houssein, Rebecca K. Reinert, et al.
Laryngoscope Investigative Otolaryngology (2024) Vol. 9, Iss. 5
Open Access
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned
Diego M. Conti, Vibeke Backer, W.J. Fokkens, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access
[Clinical value of bedside transcranial doppler ultrasound in assessing intracranial pressure in critically ill pediatric patients with nervous system disease].
Tao Zhang, Chunfeng Liu
PubMed (2022) Vol. 24, Iss. 9, pp. 973-978
Closed Access | Times Cited: 2
The chemistry of allergy in nasal polyps
Payal Yadav, Gurmeet Kaur
AIP conference proceedings (2023) Vol. 2773, pp. 030026-030026
Closed Access
A EUFOREA Comment In Reference to Cost‐Effectiveness Analysis of Inferior Turbinate Reduction and Immunotherapy in Allergic Rhinitis
Diego M. Conti, Peter W. Hellings, Peter Smith, et al.
The Laryngoscope (2023) Vol. 134, Iss. 4
Open Access
Page 1

Scroll to top